Rectal Cancer Clinical Practice Guidelines in Oncology

被引:125
作者
Benson, Al B., III
Bekaii-Saab, Tanios
Chan, Emily
Chen, Yi-Jen
Choti, Michael A.
Cooper, Harry S.
Engstrom, Paul F.
Enzinger, Peter C.
Fakih, Marwan G.
Fuchs, Charles S.
Grem, Jean L.
Hunt, Steven
Leong, Lucille A.
Lin, Edward
Martin, Michael G.
Salerno, Kilian
Mulcahy, Mary F.
Murphy, Kate
Rohren, Eric
Ryan, David P.
Saltz, Leonard
Sharma, Sunil
Shibata, David
Skibber, John M.
Small, William, Jr.
Sofocleous, Constantinos T.
Venook, Alan P.
Willett, Christopher G.
Freedman-Cass, Deborah A.
Gregory, Kristina M.
机构
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2012年 / 10卷 / 12期
关键词
TOTAL MESORECTAL EXCISION; PHASE-III TRIAL; CIRCUMFERENTIAL RESECTION MARGIN; PREOPERATIVE RADIATION-THERAPY; PATHOLOGICAL COMPLETE RESPONSE; SHORT-COURSE RADIOTHERAPY; CAPECITABINE-BASED CHEMORADIOTHERAPY; FLUOROURACIL-BASED CHEMOTHERAPY; NONPOLYPOSIS COLORECTAL-CANCER; LYMPH-NODE METASTASIS;
D O I
10.6004/jnccn.2012.0158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer. (JNCCN 2012;10:1528-1564)
引用
收藏
页码:1528 / 1564
页数:37
相关论文
共 257 条
[1]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]   ROLE OF CIRCUMFERENTIAL MARGIN INVOLVEMENT IN THE LOCAL RECURRENCE OF RECTAL-CANCER [J].
ADAM, IJ ;
MOHAMDEE, MO ;
MARTIN, IG ;
SCOTT, N ;
FINAN, PJ ;
JOHNSTON, D ;
DIXON, MF ;
QUIRKE, P .
LANCET, 1994, 344 (8924) :707-711
[3]   Family history of colorectal adenomatous polyps and increased risk for colorectal cancer [J].
Ahsan, H ;
Neugut, AI ;
Garbowski, GC ;
Jacobson, JS ;
Forde, KA ;
Treat, MR ;
Waye, JD .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) :900-+
[4]  
Altekruse S F., SEER CANC STAT REV 1
[5]   CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer [J].
André, T ;
Louvet, C ;
Maindrault-Goebel, F ;
Couteau, C ;
Mabro, M ;
Lotz, JP ;
Gilles-Amar, V ;
Krulik, M ;
Carola, E ;
Izrael, V ;
de Gramont, A .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1343-1347
[6]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[7]   Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].
Andre, Thierry ;
Boni, Corrado ;
Navarro, Matilde ;
Tabernero, Josep ;
Hickish, Tamas ;
Topham, Clare ;
Bonetti, Andrea ;
Clingan, Philip ;
Bridgewater, John ;
Rivera, Fernando ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116
[8]  
[Anonymous], 2007, CANCER, DOI DOI 10.1002/CNCR.23021
[9]  
[Anonymous], 2005, CANC PATIENT CANC SU
[10]  
[Anonymous], 2010, Dietary Reference Intakes for Calcium and Vitamin D